Biotech, Pharma Stocks Weaker Amid Trump Comments on Lower Drug Prices

Biotech and Pharma stocks (NASDAQ: IBB) are seeing early weakness following comments from Donald Trump on drug pricing in his interview for Time Person of the Year.

"I'm going to bring down drug prices," he says. "I don't like what has happened with drug prices."

You May Also Be Interested In

• Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
• Nvidia in talks to invest in Mercor at $20b valuation - The Information
• Trump admin reportedly not expecting to reach Canada tariff deal